Karen Wurster

Company: Adipo Therapeutics

Job title: Chief Executive Officer

Seminars:

Novel Approaches to Increase Caloric Expenditure for Effective Obesity Treatment by Creating Healthier Subcutaneous Fat 11:00 am

Learn how ADPO-002NP, a Notch signaling inhibitor, promotes the browning of subcutaneous, energy-storing white fat into healthier, energy-burning fat, as a novel approach to increase calorie expenditure. Uncover the potential systemic impacts of the creation and activation of subcutaneous brown fat, including full-body weight loss, improved glucose control, decreased circulating lipids, and reduced liver fat,…Read more

day: Conference Day Two